Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-02-07
1993-06-29
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544279, 424451, 424456, 424464, 424489, A61K 31505, C07D47104
Patent
active
052235033
ABSTRACT:
2-amino-4-hydroxypyrido[2,3-d]pyrimidines, having a 6-substituted ethyl or ethenyl group, are useful antineoplastic agents.
REFERENCES:
patent: 3288792 (1966-11-01), Hitchings et al.
patent: 4512992 (1985-04-01), Duch et al.
patent: 4684653 (1987-08-01), Taylor et al.
patent: 4902796 (1990-02-01), Taylor et al.
Hurlbert, et al., J. Med. Chem., 11:711-717 (1968).
Gossett, et al., The Fourth Chemical Congress of North America Book of Abstracts (Am. Chem. Soc.), MEDI-0022 (1991).
Gossett Lynn S.
Shih Chuan
Eli Lilly and Company
Fontana Steven A.
Page Thurman K.
Venkat Jyothsna
Whitaker Leroy
LandOfFree
6-substituted pyrido[2,3-d]pyrimidines as antineoplastic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6-substituted pyrido[2,3-d]pyrimidines as antineoplastic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-substituted pyrido[2,3-d]pyrimidines as antineoplastic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1755576